Episode 373 - GLP-1 Medications and Medicare - What Retirees Need to Know
About this episode
The episode discusses Medicare's new GLP-1 Bridge Program and its financial implications for retirees.
Medicare's new GLP-1 Bridge Program gives eligible retirees access to Wegovy and Zepbound for $50 a month — but there are three financial catches worth knowing before you enroll. In this episode of the Secure Your Retirement Podcast, Radon and Murs discuss one of the biggest Medicare developments of 2026 — the new GLP-1 Bridge Program, launching July 1, which allows eligible Medicare beneficiaries to access popular GLP-1 weight loss medications like Wegovy and Zepbound for a flat $50 copay per month. Joined by Peace of Mind Wealth Management's in-house Medicare specialist Sean Southard, they break down exactly what this program is, who qualifies, how the approval process works, and what the financial implications look like for retirees on fixed incomes. Listen in to learn about the three financial angles every retiree needs to understand before enrolling in the GLP-1 Bridge Program, including why that $50 copay sits completely outside your normal Medicare Part D protections, what happens when the program ends in December 2027, and how GLP-1 medications and Medicare prescription drug coverage fit into a broader retirement planning conversation around healthcare costs, budgeting…
More episodes of Secure Your Retirement
- Episode 376 - Concentrated Stock Positions How to Diversify and Minimize Capital Gains Taxes
- Episode 375 - The ROUTE to Retirement - A Complete Evaluation of Your Retirement Plan
- Episode 374 - Markets, Rates, and Retirement A Mid-Year Economic Check-In
- Episode 372 - Why So Many Retirees Feel Financially Stressed - Even with Millions
- Episode 371 - The SpaceX IPO and Retirement Smart Opportunity or Risky Chase
Explore listener stats, chart rankings, contacts and more on the Secure Your Retirement podcast page.